Rapid Dose Therapeutics Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA75339A1012
CAD
0.16
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
May'25
Feb'25
Nov'24
Aug'24
May'24
Feb'24
Nov'23
Net Sales
0.78
0.67
0.50
0.52
0.40
0.19
0.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.78
0.67
0.50
0.52
0.40
0.19
0.23
Raw Material Cost
1.00
1.17
0.95
0.83
1.01
0.46
0.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.48
0.76
0.67
0.59
0.78
0.19
0.43
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.22
0.34
0.35
0.24
0.30
0.30
0.10
Selling and Distribution Expenses
0.30
0.80
0.52
0.52
0.32
0.59
0.33
Other Expenses
-0.07
-0.11
-0.10
-0.08
-0.11
-0.02
-0.04
Total Expenditure (Excl Depreciation)
1.29
2.01
1.52
1.37
1.35
1.35
1.11
Operating Profit (PBDIT) excl Other Income
-0.5
-1.3
-1
-0.8999999999999999
-1
-1.2
-0.8999999999999999
Other Income
0.00
0.00
0.00
0.00
0.00
-0.00
0.00
Operating Profit (PBDIT)
-0.37
-1.28
-0.97
-0.81
-0.87
-0.98
-0.73
Interest
0.22
0.34
0.35
0.24
0.30
0.30
0.10
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-0.56
0.00
Gross Profit (PBDT)
-0.22
-0.50
-0.45
-0.32
-0.61
-0.26
-0.45
Depreciation
0.13
0.06
0.05
0.05
0.08
0.18
0.15
Profit Before Tax
-0.72
-1.68
-1.36
-1.10
-1.26
-2.05
-0.98
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-0.72
-1.68
-1.36
-1.10
-1.26
-2.05
-0.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-0.72
-1.68
-1.36
-1.10
-1.26
-2.05
-0.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-0.72
-1.68
-1.36
-1.10
-1.26
-2.05
-0.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-5.32
-5.21
-4.10
-3.76
-3.31
-3.16
-4.54
Earnings per share (EPS)
-0.01
-0.01
-0.01
-0.01
-0.01
-0.02
-0.01
Diluted Earnings per share
-0.01
-0.01
-0.01
-0.01
-0.01
-0.02
-0.01
Operating Profit Margin (Excl OI)
-64.4%
-200.93%
-202.66%
-166.21%
-239.16%
-602.61%
-375.72%
Gross Profit Margin
-75.36%
-242.63%
-262.38%
-203.41%
-294.27%
-972.4%
-354.23%
PAT Margin
-92.45%
-251.55%
-271.98%
-213.15%
-315.0%
-1066.23%
-419.6%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended May 2025 is 60.00%

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended May 2025 is 50.00%

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended May 2025 is 60.00%

stock-summary

Interest

QoQ Growth in quarter ended May 2025 is -33.33%

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended May 2025 has improved from Nov 2024

Compare Quarterly Results Of Rapid Dose Therapeutics Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
Net Sales
0.78
0.03
0.75
2,500.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.78
0.03
0.75
2,500.00%
Raw Material Cost
1.00
0.01
0.99
9,900.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.48
0.52
-0.04
-7.69%
Power Cost
0
0
0.00
Manufacturing Expenses
0.22
1.33
-1.11
-83.46%
Selling and Distribution Expenses
0.30
0.87
-0.57
-65.52%
Other Expenses
-0.07
-0.18
0.11
61.11%
Total Expenditure (Excl Depreciation)
1.29
0.92
0.37
40.22%
Operating Profit (PBDIT) excl Other Income
-0.50
-0.89
0.39
43.82%
Other Income
0.00
0.10
-0.10
-100.00%
Operating Profit (PBDIT)
-0.37
-0.79
0.42
53.16%
Interest
0.22
1.33
-1.11
-83.46%
Exceptional Items
0.00
0.09
-0.09
-100.00%
Gross Profit (PBDT)
-0.22
0.02
-0.24
-1,200.00%
Depreciation
0.13
0.01
0.12
1,200.00%
Profit Before Tax
-0.72
-2.04
1.32
64.71%
Tax
0.00
0.00
0.00
Provisions and contingencies
0
0.00
0.00
Profit After Tax
-0.72
-2.04
1.32
64.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-0.72
-2.04
1.32
64.71%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.72
-2.04
1.32
64.71%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-5.32
-15.20
9.88
65.00%
Earnings per share (EPS)
-0.01
-0.02
0.01
50.00%
Diluted Earnings per share
-0.01
-0.02
0.01
50.00%
Operating Profit Margin (Excl OI)
-64.40%
-3,063.02%
0.00
2,998.62%
Gross Profit Margin
-75.36%
-6,961.23%
0.00
6,885.87%
PAT Margin
-92.45%
-6,985.20%
0.00
6,892.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 0.08 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 60.00%

stock-summary

YoY Growth in quarter ended May 2025 is 100.00% vs 100.00% in May 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.07 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 50.00%

stock-summary

YoY Growth in quarter ended May 2025 is 46.15% vs -116.67% in May 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.04 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 60.00%

stock-summary

YoY Growth in quarter ended May 2025 is 55.56% vs -200.00% in May 2024

Quarterly - Interest
Interest 0.02 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is -33.33%

stock-summary

YoY Growth in quarter ended May 2025 is -33.33% vs 200.00% in May 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -64.40%
in May 2025

Figures in %
stock-summary

QoQ Growth in quarter ended May 2025 has improved from Nov 2024

stock-summary

YoY Growth in quarter ended May 2025 has improved from May 2024